Gabica CR Tablet 82.5mg

About Gabica CR Tablet 82.5mg

Gabica CR Tablet 82.5mg Uses

• Relieves nerve pain caused by diabetic peripheral neuropathy
• Eases pain associated with postherpetic neuralgia after shingles
• Used as an add-on treatment for partial-onset seizures in epilepsy
• Helps manage chronic pain linked to fibromyalgia

Gabica CR Tablet 82.5mg Benefits

• Once or twice daily controlled-release dosing improves treatment adherence
• Steady drug release reduces peak-related side effects compared to immediate-release capsules
• Helps reduce nighttime nerve pain flare-ups that disturb sleep
• Supports better daily functioning in people with chronic neuropathic pain

What Experts Say

Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the nervous system. This reduces release of excitatory neurotransmitters and calms overactive nerve signals behind chronic pain and seizures. Clinical guidelines often list Pregabalin as a first-line option for diabetic neuropathy and postherpetic neuralgia.

The controlled-release formulation releases the drug gradually, keeping blood levels steadier over the day compared to standard capsules. This format suits patients needing consistent pain control with fewer daily doses, and may reduce dizziness spikes seen after immediate-release doses. Dose is usually adjusted gradually based on kidney function and pain response.

Experts caution that Pregabalin can cause dependence and withdrawal symptoms if stopped suddenly, so tapering under medical supervision matters. It is avoided in pregnancy unless clearly necessary, and combining it with other sedating medicines or alcohol raises drowsiness risk. Regular follow-up helps balance pain relief against side effects like weight gain or blurred vision.

Drug Class

• Gabapentinoid (Anticonvulsant and Neuropathic Pain Agent)

Gabica CR Tablet 82.5mg formula

• Pregabalin

Available forms

• Tablet

How to use Gabica CR Tablet 82.5mg?

• Swallow the tablet whole with a glass of water, do not crush, chew or split it
• Take with or without food, at roughly the same time each day
• Follow the exact dose and schedule prescribed by your doctor
• Do not stop taking this medicine suddenly without medical advice

Drug Interactions

• Increased sedation when combined with opioids, benzodiazepines or other CNS depressants
• Enhanced dizziness and drowsiness with alcohol
• Additive central nervous system effects when combined with other anticonvulsants
• Possible increased risk of swelling or angioedema when combined with ACE inhibitors

Risks and warnings

• May cause dizziness, drowsiness or blurred vision, avoid driving until effects are known
• Carries a risk of dependence, use cautiously in patients with a history of substance misuse
• Requires dose adjustment in patients with kidney impairment
• May cause swelling of the hands and feet
• Avoid alcohol while taking this medicine
• Not advised during pregnancy or breastfeeding unless prescribed by a doctor
• Sudden discontinuation may trigger withdrawal symptoms such as insomnia, nausea or anxiety

Gabica CR Tablet 82.5mg Side Effects

• Dizziness
• Drowsiness
• Blurred vision
• Weight gain
• Dry mouth
• Swelling of hands and feet (peripheral edema)
• Difficulty concentrating
• Headache
• Fatigue
• Nausea
• Rare mood changes or thoughts of self-harm, report to a doctor immediately

Storage Conditions

• Store below 30°C in a cool, dry place away from direct sunlight
• Keep the tablet in its original strip until the time of use
• Keep out of reach of children
• Do not store in the bathroom or near moisture